Varex Imaging Corporation (VREX)
VREX Stock Price Chart
Explore Varex Imaging Corporation interactive price chart. Choose custom timeframes to analyze VREX price movements and trends.
VREX Company Profile
Discover essential business fundamentals and corporate details for Varex Imaging Corporation (VREX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
23 Jan 2017
Employees
2.30k
Website
https://www.vareximaging.comCEO
Sunny S. Sanyal
Description
Varex Imaging Corporation (VREX) specializes in the development and production of X-ray imaging components. Its operations are divided into two primary divisions: Medical and Industrial. Within the Medical segment, Varex provides a comprehensive range of X-ray imaging components. These include essential hardware like X-ray tubes, digital detectors, and high-voltage connectors, alongside sophisticated software solutions for image processing, 3D reconstruction, and computer-aided diagnostics. The segment also supplies critical ancillary devices such as collimators, generators, and automatic exposure control mechanisms. These medical products serve a wide spectrum of applications, from general diagnostic imaging like radiography and fluoroscopy, to specialized areas such as mammography, computed tomography (CT), cardiac procedures, dental imaging, and surgical applications. They are also vital for radiation therapy, oncology, and advanced computer-aided detection systems. The Industrial segment focuses on providing X-ray technology for security and industrial inspection. Its offerings include Linatron X-ray accelerators, X-ray tubes, digital detectors, and high-voltage connectors. These components are crucial for diverse applications such as airport security scanning, cargo screening at border crossings, and nondestructive testing across various industries. Varex distributes its products through multiple channels, including direct sales to end-users, partnerships with imaging system Original Equipment Manufacturers (OEMs), independent service providers, and a network of distributors. With a significant global footprint, the company maintains operations across North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Established in 2016, Varex Imaging Corporation is headquartered in Salt Lake City, Utah.
VREX Financial Timeline
Browse a chronological timeline of Varex Imaging Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 Aug 2026
EPS estimate is $0.22, while revenue estimate is $215.50m.
Earnings released on 7 May 2026
EPS came in at $0.21 falling short of the estimated $0.22 by -4.55%, while revenue for the quarter reached $216.00m , missing expectations by -0.42%.
Earnings released on 10 Feb 2026
EPS came in at $0.19 surpassing the estimated $0.14 by +35.71%, while revenue for the quarter reached $209.60m , beating expectations by +0.87%.
Earnings released on 18 Nov 2025
EPS came in at $0.37 surpassing the estimated $0.18 by +105.56%, while revenue for the quarter reached $228.90m , beating expectations by +11.24%.
Earnings released on 7 Aug 2025
EPS came in at $0.18 surpassing the estimated $0.04 by +350.00%, while revenue for the quarter reached $203.00m , missing expectations by -7.42%.
Earnings released on 8 May 2025
EPS came in at $0.26 surpassing the estimated $0.14 by +85.71%, while revenue for the quarter reached $212.90m , beating expectations by +1.66%.
Earnings released on 6 Feb 2025
EPS came in at $0.07 surpassing the estimated $0.04 by +75.00%, while revenue for the quarter reached $199.80m , missing expectations by -1.16%.
Earnings released on 19 Nov 2024
EPS came in at $0.19 surpassing the estimated $0.09 by +111.11%, while revenue for the quarter reached $205.70m , beating expectations by +8.59%.
Earnings released on 1 Aug 2024
EPS came in at $0.14 falling short of the estimated $0.19 by -26.32%, while revenue for the quarter reached $209.10m , beating expectations by +4.12%.
Earnings released on 2 May 2024
EPS came in at $0.16 falling short of the estimated $0.23 by -30.43%, while revenue for the quarter reached $206.20m , beating expectations by +0.51%.
Earnings released on 6 Feb 2024
EPS came in at $0.06 falling short of the estimated $0.11 by -45.45%, while revenue for the quarter reached $190.00m , beating expectations by +1.08%.
Earnings released on 14 Nov 2023
EPS came in at $0.45 surpassing the estimated $0.33 by +36.36%, while revenue for the quarter reached $227.40m , missing expectations by -2.12%.
Earnings released on 1 Aug 2023
EPS came in at $0.37 surpassing the estimated $0.33 by +12.12%, while revenue for the quarter reached $232.20m , missing expectations by -0.06%.
Earnings released on 2 May 2023
EPS came in at $0.26 surpassing the estimated $0.17 by +52.94%, while revenue for the quarter reached $228.20m , beating expectations by +6.08%.
Earnings released on 31 Jan 2023
EPS came in at $0.08 falling short of the estimated $0.11 by -27.27%, while revenue for the quarter reached $205.60m , missing expectations by -0.04%.
Earnings released on 15 Nov 2022
EPS came in at $0.32 surpassing the estimated $0.21 by +52.38%, while revenue for the quarter reached $231.40m , beating expectations by +3.64%.
Earnings released on 2 Aug 2022
EPS came in at $0.20 falling short of the estimated $0.21 by -4.76%, while revenue for the quarter reached $214.50m , beating expectations by +3.72%.
Earnings released on 3 May 2022
EPS came in at $0.37 surpassing the estimated $0.23 by +60.87%, while revenue for the quarter reached $214.70m , beating expectations by +6.37%.
Earnings released on 8 Feb 2022
EPS came in at $0.25 falling short of the estimated $0.30 by -16.67%, while revenue for the quarter reached $198.80m , missing expectations by -4.55%.
Earnings released on 16 Nov 2021
EPS came in at $0.45 surpassing the estimated $0.38 by +18.42%, while revenue for the quarter reached $226.30m , beating expectations by +7.80%.
Earnings released on 3 Aug 2021
EPS came in at $0.40 surpassing the estimated $0.27 by +48.15%, while revenue for the quarter reached $211.20m , beating expectations by +2.95%.
VREX Stock Performance
Access detailed VREX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
